Upcoming event

Comprehensive assessment of immuno-oncology biomarkers in adenocarcinoma, urothelial carcinoma, and squamous-cell carcinoma of the bladder

European Urology, April 2020

The importance of hospital and surgeon volume as major determinants of morbidity and mortality after radical cystectomy for bladder cancer: a systematic review and recommendations by the European Association of Urology muscle-invasive and metastatic bladder cancer guideline panel

European Urology Oncology, December 2020

What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review

European Urology Oncology, Volume 2, Issue 6, Pages 625-642

Rucaparib for recurrent, locally advanced, or metastatic urothelial carcinoma (mUC): Results from ATLAS, a phase II open-label trial

Phase III trial on nadofaragene firadenovec for high-grade, BCG unresponsive NMIBC patients

Randomized phase III trial of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as perioperative chemotherapy for muscle invasive urothelial bladder cancer (MIUBC): Preliminary results of the GETUG/AFU V05 VESPER trial on toxicity and pathological responses

Study EV-103: Preliminary durability results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma

Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma

Journal of Urology, November 2020

Non-visible haematuria for the detection of bladder, upper tract, and kidney cancer: an updated systematic review and meta-analysis

European Urology, November 2019

Long-term oncologic outcomes of laparoscopic versus open radical nephroureterectomy for patients with T3N0M0 upper tract urothelial carcinoma: A multicenter cohort study with adjustment by propensity score matching

Annals of Surgical Oncology, October 2020

Prospective assessment of vesical imaging reporting and data system (VI-RADS) and its clinical impact on the management of high-risk non–muscle-invasive bladder cancer patients candidate for repeated transurethral resection

European Urology, Volume 77, Issue 1, January 2020, Pages 101-109

Surgical safety of radical cystectomy and pelvic lymph node dissection following neoadjuvant pembrolizumab in patients with bladder cancer: Prospective assessment of perioperative outcomes from the PURE-01 trial

European Uroloby, December 2019

Next